Primary tumor radiotherapy for metastatic hormone-sensitive prostate cancer
Methodological advances with new framework adaptive meta-analysis
0 COMENTÁRIOSMethodological advances with new framework adaptive meta-analysis
0 COMENTÁRIOSWhat is the right choice?
1 COMENTÁRIOSStill a double standard evaluation
0 COMENTÁRIOSDealing with fast therapeutic metamorphosis
0 COMENTÁRIOS